Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-001471
Filing Date
2019-05-13
Accepted
2019-05-10 18:03:24
Documents
51
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xenetic_10q-033119.htm 10-Q 320379
2 CERTIFICATION xenetic_10q-ex3101.htm EX-31.1 9737
3 CERTIFICATION xenetic_10q-ex3102.htm EX-31.2 9864
4 CERTIFICATION xenetic_10q-ex3201.htm EX-32.1 4246
  Complete submission text file 0001683168-19-001471.txt   1709150

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbio-20190331.xml EX-101.INS 195496
6 XBRL SCHEMA FILE xbio-20190331.xsd EX-101.SCH 21909
7 XBRL CALCULATION FILE xbio-20190331_cal.xml EX-101.CAL 34929
8 XBRL DEFINITION FILE xbio-20190331_def.xml EX-101.DEF 90742
9 XBRL LABEL FILE xbio-20190331_lab.xml EX-101.LAB 158275
10 XBRL PRESENTATION FILE xbio-20190331_pre.xml EX-101.PRE 138340
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 19816321
SIC: 2834 Pharmaceutical Preparations